{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:08:05Z","timestamp":1791727685699,"version":"4.3.4"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY633"],"award-info":[{"award-number":["2023KY633"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Meningococcal vaccination in Chinese national immunization program (NIP) includes polysaccharide vaccine against Neisseria meningitidis serogroup A (MPV-A) and polysaccharide vaccine against Neisseria meningitidis serogroup A and C(MPV-AC). This study aimed to assess the cost-effectiveness of an alternative strategy using polysaccharide conjugate vaccine against Neisseria meningitidis serogroup A,C,W,Y(MCV-ACWY) and polysaccharide vaccine against Neisseria meningitidis serogroup A,C,W,Y(MPV-ACWY). From a societal perspective, we constructed a decision tree-Markov model to simulate the economic and health consequences of meningococcal disease in a 2023 birth cohort with the current meningococcal vaccination strategy and the alternative. Parameters of epidemiology, vaccine efficacy, cost, and utility were extracted from database and previous literatures. The sensitivity analysis was implemented to evaluate the robustness of the model. Compared to the current practice, the alternative strategy could avoid 513 meningococcal disease cases, 53 sequelae and 47 deaths. The ICER was estimated at $16899.81 \/QALY, under the threshold of one time of the GDP per capita of Zhejiang province in 2023. The incidence of meningococcemia, the incidence of meningococcal meningitis, the case fatality of meningococcemia, the vaccine efficacy of MCV-ACWY and the price of MCV-ACWY would influence the cost-effectiveness of the meningococcal vaccination strategies. At the threshold, the probability of cost-effectiveness was 14.76% for the current strategy and 55.98% for the alternative strategy, respectively. The current meningococcal vaccination strategy had effectively prevented meningococcal disease at a low cost, but with limited serogroup coverage. Strategy using MCV-ACWY and MPV-ACWY could increase health benefits at a substantial cost at a cost-effective manner.<\/jats:p>","DOI":"10.1371\/journal.pone.0310274","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:25:53Z","timestamp":1725902753000},"page":"e0310274","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China"],"prefix":"10.1371","volume":"19","author":[{"given":"Jianyong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2950-1215","authenticated-orcid":true,"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"issue":"6","key":"pone.0310274.ref001","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QCO.0000000000000606","article-title":"Neisseria meningitidis and meningococcal disease: recent discoveries and innovations.","volume":"32","author":"RC Read","year":"2019","journal-title":"Curr Opin Infect Dis."},{"issue":"11","key":"pone.0310274.ref002","first-page":"e48509","article-title":"An Overview of Meningococcal Disease\u2019s Recent Diagnostic and Treatment Model.","volume":"15","author":"D Chhabria","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"pone.0310274.ref003","doi-asserted-by":"crossref","first-page":"e024343","DOI":"10.1136\/bmjopen-2018-024343","article-title":"Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis","volume":"9","author":"ME Peterson","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0310274.ref004","first-page":"81","article-title":"Expert consensus on immunization with meningococcal vaccines in China (2023 version) Chinese Preventive Medicine Association","volume":"24","author":"WU Jiang","year":"2023","journal-title":"Chinese Prevention Medicine."},{"issue":"5","key":"pone.0310274.ref005","first-page":"429","article-title":"Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI).","volume":"76","author":"J Li","journal-title":"J Infect. 2018 May"},{"issue":"3","key":"pone.0310274.ref006","first-page":"241","article-title":"Serogroup distribution of meningococcal meningitis in China, 2015\u20132019.","volume":"26","author":"Li Junhong","year":"2020","journal-title":"Chinese Journal of Vaccines and Immunization"},{"issue":"5","key":"pone.0310274.ref007","first-page":"481","article-title":"Epidemiological characteristics of meningococcal meningitis and switching trend of serogroups of Neisseria meningitidis in China, 2006\u20132014.","volume":"21","author":"Li Junhong","year":"2015","journal-title":"Chinese Journal of Vaccines and Immunization"},{"issue":"6","key":"pone.0310274.ref008","first-page":"541","article-title":"Epidemiologic trend of serogroup switching of Neisseria meningitidis strains in China","volume":"13","year":"2007","journal-title":"Chinese Journal of Vaccines and Immunization"},{"issue":"34","key":"pone.0310274.ref009","doi-asserted-by":"crossref","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","article-title":"Vaccination Coverage Among Adolescents Aged 13\u201317 Years\u2014National Immunization Survey-Teen, United States, 2022.","volume":"72","author":"C Pingali","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pone.0310274.ref010","first-page":"e2022069","article-title":"Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges.","volume":"93","author":"P Ferrara","year":"2022","journal-title":"Acta Biomed."},{"issue":"5","key":"pone.0310274.ref011","doi-asserted-by":"crossref","first-page":"2071077","DOI":"10.1080\/21645515.2022.2071077","article-title":"Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010\u20132020: a systematic review and meta-analysis.","volume":"18","author":"J Xu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"pone.0310274.ref012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.","volume":"24","author":"M Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"pone.0310274.ref013","first-page":"e158","article-title":"Impact and effectiveness of meningococcal vaccines: a review.","volume":"41","author":"L Helena De Oliveira","year":"2017","journal-title":"Rev Panam Salud Publica."},{"issue":"8447","key":"pone.0310274.ref014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"2","author":"AL Reingold","year":"1985","journal-title":"Lancet"},{"issue":"2","key":"pone.0310274.ref015","doi-asserted-by":"crossref","first-page":"e20162193","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine","volume":"139","author":"AC Cohn","year":"2017","journal-title":"Pediatrics"},{"issue":"10015","key":"pone.0310274.ref016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(15)00554-1","article-title":"Under-5 mortality in 2851 Chinese counties, 1996\u20132012: a subnational assessment of achieving MDG 4 goals in China.","volume":"387","author":"Y Wang","year":"2016","journal-title":"Lancet"},{"key":"pone.0310274.ref017","author":"World Health Organization","year":"2019","journal-title":"WHO guide for standardization of economic evaluations of immunization programmes"},{"key":"pone.0310274.ref018","author":"Chinese ministry of health","year":"2021","journal-title":"Overview of notifiable infectious diseases in China in"},{"issue":"5","key":"pone.0310274.ref019","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"K Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pone.0310274.ref020","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315.","volume":"6","author":"B Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"17","key":"pone.0310274.ref021","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2169\/internalmedicine.47.1046","article-title":"Meningococcemia without meningitis in Japan","volume":"47","author":"T Horino","year":"2008","journal-title":"Intern Med"},{"issue":"6","key":"pone.0310274.ref022","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/eri.13.42","article-title":"The burden and impact of severe and long-term sequelae of meningococcal disease.","volume":"11","author":"A Vyse","year":"2013","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"2 Suppl","key":"pone.0310274.ref023","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","article-title":"Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements","volume":"59","author":"F. Martin\u00f3n-Torres","year":"2016","journal-title":"J Adolesc Health."},{"key":"pone.0310274.ref024","author":"World Health Organization","year":"2005","journal-title":"Monitoring vaccine wastage at country level: guidelines for programme managers"},{"issue":"21","key":"pone.0310274.ref025","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.vaccine.2018.04.008","article-title":"Routine immunization services costs and financing in China, 2015.","volume":"36","author":"W Yu","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"pone.0310274.ref026","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ane.13485","article-title":"Direct economic burden of patients with tuberculous meningitis in western China.","volume":"144","author":"XP Ma","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"pone.0310274.ref027","first-page":"582","article-title":"Evaluation progress of socioeconomic burden of diagnosis and treatment of myopia","volume":"37","author":"Y. Yang","year":"2019","journal-title":"Clin J Experiment Ophthalmol"},{"issue":"4","key":"pone.0310274.ref028","first-page":"224","article-title":"Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China.","volume":"92","author":"A Wang","year":"2012","journal-title":"National Med J China"},{"issue":"6","key":"pone.0310274.ref029","first-page":"648","article-title":"Safety of a domestic group A, C, Y, and W135 meningococcal conjugate vaccine among 3-month-old, 6\u201323-month-old, and 2\u20136-year-old children: a phase III clinical trial.","volume":"27","author":"Z Xie","year":"2021","journal-title":"Chin J Vaccines Immun."},{"issue":"3","key":"pone.0310274.ref030","first-page":"245","article-title":"Immunogenicity and persistence of immunity following a booster of group a and group C meningococcal polysaccharide vaccine among children who had received primary vaccination with group a and group C meningococcal polysaccharide conjugate vaccine","volume":"26","author":"J Tang","year":"2020","journal-title":"Chin J Vaccines Immun"},{"issue":"1","key":"pone.0310274.ref031","first-page":"43","article-title":"Parents\u2019 utilities for outcomes of occult bacteremia.","volume":"154","author":"JE Bennett","year":"2000","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"8","key":"pone.0310274.ref032","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0895-4356(02)00448-1","article-title":"The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.","volume":"55","author":"R Oostenbrink","year":"2002","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"pone.0310274.ref033","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.85.3.327","article-title":"Utility values associated with blindness in an adult population","volume":"85","author":"MM Brown","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"pone.0310274.ref034","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00005373-199804000-00011","article-title":"Long-term psychosocial adaptation of children who survive burns involving 80% or greater total body surface area","volume":"44","author":"P Blakeney","year":"1998","journal-title":"J Trauma"},{"issue":"5","key":"pone.0310274.ref035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/322587","article-title":"Complications of meningococcal disease in college students","volume":"33","author":"LJ Erickson","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0310274.ref036","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2105\/AJPH.85.6.843","article-title":"Should college students be vaccinated against meningococcal disease? A cost-benefit analysis","volume":"85","author":"LA Jackson","year":"1995","journal-title":"Am J Public Health."},{"issue":"25\u201326","key":"pone.0310274.ref037","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/S0264-410X(01)00066-4","article-title":"Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis","volume":"19","author":"I Parent du Ch\u00e2telet","year":"2001","journal-title":"Vaccine"},{"issue":"29","key":"pone.0310274.ref038","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.vaccine.2007.04.071","article-title":"Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis","volume":"25","author":"P De Wals","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"pone.0310274.ref039","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/INF.0000000000001512","article-title":"Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.","volume":"36","author":"P De Wals","year":"2017","journal-title":"Pediatr Infect Dis J."},{"issue":"5","key":"pone.0310274.ref040","doi-asserted-by":"crossref","first-page":"e0175721","DOI":"10.1371\/journal.pone.0175721","article-title":"Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.","volume":"12","author":"TE Delea","year":"2017","journal-title":"PLoS One."},{"issue":"1","key":"pone.0310274.ref041","doi-asserted-by":"crossref","first-page":"2313872","DOI":"10.1080\/21645515.2024.2313872","article-title":"Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.","volume":"20","author":"H Zhang","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"pone.0310274.ref042","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2021.1880209","article-title":"Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine","volume":"17","author":"SV Watle","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"pone.0310274.ref043","doi-asserted-by":"crossref","first-page":"e0188595","DOI":"10.1371\/journal.pone.0188595","article-title":"Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt","volume":"12","author":"A Kuznik","year":"2017","journal-title":"PLoS One"},{"issue":"26","key":"pone.0310274.ref044","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.vaccine.2022.04.101","article-title":"A comparison of national vaccination policies to prevent serogroup B meningococcal disease","volume":"40","author":"G Sulis","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"pone.0310274.ref045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jval.2020.09.004","article-title":"Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease.","volume":"24","author":"E Beck","year":"2021","journal-title":"Value Health"},{"issue":"3","key":"pone.0310274.ref046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cvfa.2019.07.001","article-title":"Herd Immunity.","volume":"35","author":"DR Smith","year":"2019","journal-title":"Vet Clin North Am Food Anim Pract"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0320386","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:26:25Z","timestamp":1725902785000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310274"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310274","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]}}}